Under Diabetes Management section from The Journal of Clinical Endocrinology & Metabolism published on 23 March 2019. Type 2 diabetes mellitus (T2DM) is considered to be one of the most common metabolic diseases in individuals over the age of 65 years. The incidence of newly diagnosed diabetes is reportedly highest in individuals aged between 65 and 79 years. Furthermore, elderly patients are more susceptible to diabetes-related complications.
Therefore, the US Endocrine Society along with the European Society of Endocrinology, the Obesity Society and the Gerontological Society of America has developed the present guideline to improve the overall health and quality of life of diabetic patients aged 65 years and older. What Is This Guideline About? The present guideline has been developed by the Endocrine Society to provide evidence-based recommendations to healthcare providers on the…
